Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute and chronic demyelinating disease.

A B Gruber

    Otolaryngologic Clinics of North America
    |February 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    This study differentiates between dysmyelinating and myelinoclastic diseases, both affecting central nervous system myelin. Dysmyelinating diseases stem from genetic defects in myelin formation, typically seen in children, while myelinoclastic diseases involve an attack on previously normal myelin.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    MELAS syndrome involving a mother and two children.

    Archives of neurology·1987
    Same author

    Mitochondrial myopathy presenting as temporomandibular dysfunction.

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·1987
    Same author

    Low CSF glucose level (hypoglycorrhachia) in symptomatic hypoglycemia.

    JAMA·1982
    See all related articles

    Area of Science:

    • Neuroscience
    • Genetics
    • Pathology

    Background:

    • Central nervous system (CNS) myelin destruction with relative axonal sparing defines a group of neurological disorders.
    • These disorders are broadly categorized into hereditary dysmyelinating diseases and acquired myelinoclastic conditions.

    Purpose of the Study:

    • To elucidate the distinct pathological mechanisms underlying dysmyelinating and myelinoclastic diseases.
    • To differentiate between genetic defects in myelin formation and external attacks on established myelin.

    Main Methods:

    • Review of existing literature on CNS myelin disorders.
    • Comparative analysis of genetic and acquired etiologies.
    • Pathological characterization of myelin and axonal damage.

    Related Experiment Videos

    Main Results:

    • Dysmyelinating diseases result from intrinsic genetic defects affecting myelin development or maintenance.
    • Myelinoclastic diseases involve exogenous or endogenous factors that damage pre-existing myelin.
    • Both conditions primarily impact myelin sheaths, with axons often remaining structurally intact.

    Conclusions:

    • A clear distinction exists between inherited dysmyelination and acquired myelinolysis based on underlying etiology.
    • Understanding these differences is crucial for accurate diagnosis and targeted therapeutic strategies in CNS myelin disorders.